Genome-Wide Association Study of Pancreatic Cancer in Japanese Population

Pancreatic cancer shows very poor prognosis and is the fifth leading cause of cancer death in Japan. Previous studies indicated some genetic factors contributing to the development and progression of pancreatic cancer; however, there are limited reports for common genetic variants to be associated with this disease, especially in the Asian population. We have conducted a genome-wide association study (GWAS) using 991 invasive pancreatic ductal adenocarcinoma cases and 5,209 controls, and identified three loci showing significant association (P-value<5×10−7) with susceptibility to pancreatic cancer. The SNPs that showed significant association carried estimated odds ratios of 1.29, 1.32, and 3.73 with 95% confidence intervals of 1.17–1.43, 1.19–1.47, and 2.24–6.21; P-value of 3.30×10−7, 3.30×10−7, and 4.41×10−7; located on chromosomes 6p25.3, 12p11.21 and 7q36.2, respectively. These associated SNPs are located within linkage disequilibrium blocks containing genes that have been implicated some roles in the oncogenesis of pancreatic cancer.

[1]  Martin Kupiec,et al.  The yeast VPS genes affect telomere length regulation , 2004, Current Genetics.

[2]  L. Groop,et al.  Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus , 2008, Nature Genetics.

[3]  Yusuke Nakamura,et al.  Japanese population structure, based on SNP genotypes from 7003 individuals compared to other ethnic groups: effects on population-based association studies. , 2008, American journal of human genetics.

[4]  W. Greenhalf,et al.  Molecular Diagnosis of Early Pancreatic Ductal Adenocarcinoma in High-Risk Patients , 2001, Pancreatology.

[5]  Scott E Kern,et al.  Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia. , 2002, The American journal of pathology.

[6]  F. Real,et al.  Comparative analysis of mutations in the p53 and K‐ras genes in pancreatic cancer , 1994, International journal of cancer.

[7]  A. Roddam,et al.  Pancreatic cancer in type 1 and young-onset diabetes: systematic review and meta-analysis , 2007, British Journal of Cancer.

[8]  Maxim S. Petrov,et al.  Early Prediction of Severity in Acute Pancreatitis Using Infrared Spectroscopy of Serum , 2007, Pancreatology.

[9]  H. Friess,et al.  Real-Time Quantitative PCR of Telomerase mRNA Is Useful for the Differentiation of Benign and Malignant Pancreatic Disorders , 2001, Pancreas.

[10]  A. Ziegler,et al.  BRCA2 germline mutations in familial pancreatic carcinoma. , 2003, Journal of the National Cancer Institute.

[11]  R. Hruban,et al.  Epidemiology and risk factors , 2002 .

[12]  Scott E. Kern,et al.  DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 , 1996, Science.

[13]  F. Suzuki,et al.  Shortened telomere length and increased telomerase activity in hamster pancreatic duct adenocarcinomas and cell lines , 1997, Molecular carcinogenesis.

[14]  M. Sivak,et al.  Long-term follow-up of patients with clinically indeterminate suspicion of pancreatic cancer and normal EUS. , 2003, Gastrointestinal endoscopy.

[15]  H. Thaler,et al.  Pain as a predictor of outcome in patients with operable pancreatic carcinoma. , 1997, Surgery.

[16]  C. la Vecchia,et al.  Family history and the risk of liver, gallbladder, and pancreatic cancer. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[17]  R. Hruban,et al.  Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma , 1994, Nature Genetics.

[18]  S. Macleod,et al.  The genetics of nicotine dependence: relationship to pancreatic cancer. , 2006, World journal of gastroenterology.

[19]  P. Hall,et al.  Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer. , 1991, British Journal of Cancer.

[20]  J. Cameron,et al.  Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[21]  Leonid Kruglyak,et al.  Telomere Length as a Quantitative Trait: Genome-Wide Survey and Genetic Mapping of Telomere Length-Control Genes in Yeast , 2006, PLoS genetics.

[22]  Wei Zheng,et al.  A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33 , 2010, Nature Genetics.

[23]  A. Andrén-sandberg,et al.  Pancreatitis and the risk of pancreatic cancer , 1993 .

[24]  Sridhar Hannenhalli,et al.  The evolution of Fox genes and their role in development and disease , 2009, Nature Reviews Genetics.

[25]  Franco Mosca,et al.  Cancer Risk among the Relatives of Patients with Pancreatic Ductal Adenocarcinoma , 2007, Pancreatology.

[26]  Zhiwei Wang,et al.  Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells. , 2007, Cancer research.

[27]  N. Samani,et al.  A regulatory SNP of the BICD1 gene contributes to telomere length variation in humans. , 2008, Human molecular genetics.

[28]  Alison P. Klein,et al.  Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene , 2009, Science.

[29]  M. de Andrade,et al.  Risk of malignancy in first‐degree relatives of patients with pancreatic carcinoma , 2005, Cancer.

[30]  Akhilesh Pandey,et al.  Identification of novel highly expressed genes in pancreatic ductal adenocarcinomas through a bioinformatics analysis of expressed sequence tags , 2004, Cancer biology & therapy.

[31]  J. Fraumeni,et al.  Cancer epidemiology and prevention. , 2006 .

[32]  K. Mossman.  The Wellcome Trust Case Control Consortium, U.K. , 2008 .

[33]  F. Mícek.  [Cancer of the pancreas]. , 1965, Bratislavske lekarske listy.

[34]  Martin Kupiec,et al.  A genome-wide screen for Saccharomyces cerevisiae deletion mutants that affect telomere length. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M. McCarthy,et al.  Genome-wide association studies for complex traits: consensus, uncertainty and challenges , 2008, Nature Reviews Genetics.

[36]  G. Parmigiani,et al.  Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.

[37]  T. Hansen,et al.  SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations , 2008, Nature Genetics.

[38]  Geoffrey S. Tobias,et al.  Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer , 2009, Nature Genetics.

[39]  W. Greenhalf,et al.  Molecular analysis to detect pancreatic ductal adenocarcinoma in high-risk groups. , 2005, Gastroenterology.

[40]  N. Malats,et al.  The Inherited Genetic Component of Sporadic Pancreatic Adenocarcinoma , 2009, Pancreatology.

[41]  E. Lam,et al.  The emerging roles of forkhead box (Fox) proteins in cancer , 2007, Nature Reviews Cancer.

[42]  A. Andrén-sandberg,et al.  Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. , 1993, The New England journal of medicine.

[43]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.